Global network analysis of drug tolerance, mode of action and virulence in methicillin-resistant S. aureus

BMC Systems Biology

Volumn 5, Issue , 2011, Pages

  Overton, Ian M ^a,b   Graham, Shirley ^c   Gould, Katherine A ^d   Hinds, Jason ^d   Botting, Catherine H ^c   Shirran, Sally ^c   Barton, Geoffrey J ^b   Coote, Peter J ^c  

^a WESTERN GENERAL HOSPITAL   (United Kingdom)

^b UNIVERSITY OF DUNDEE   (United Kingdom)

^c UNIVERSITY OF ST ANDREWS   (United Kingdom)

^d ST GEORGE'S UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIA (MICROORGANISMS); METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; POSIBACTERIA; STAPHYLOCOCCUS AUREUS;

ANTIINFECTIVE AGENT; CYCLOPEPTIDE; RANALEXIN; VIRULENCE FACTOR;

ARTICLE; BAYES THEOREM; BIOLOGY; CELL WALL; CHEMISTRY; DRUG EFFECT; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENETICS; HUMAN; METABOLISM; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; METHODOLOGY; MICROBIOLOGICAL EXAMINATION; PENICILLIN RESISTANCE; REGRESSION ANALYSIS; STAPHYLOCOCCUS AUREUS; SYSTEMS BIOLOGY; VIRULENCE;

ANTI-INFECTIVE AGENTS; BAYES THEOREM; CELL WALL; COMPUTATIONAL BIOLOGY; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, BACTERIAL; HUMANS; METHICILLIN RESISTANCE; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; MICROBIAL SENSITIVITY TESTS; PEPTIDES, CYCLIC; REGRESSION ANALYSIS; STAPHYLOCOCCUS AUREUS; SYSTEMS BIOLOGY; VIRULENCE; VIRULENCE FACTORS;

EID: 79955838835     PISSN: None     EISSN: 17520509     Source Type: Journal    
DOI: 10.1186/1752-0509-5-68     Document Type: Article

References (104)

1. Delaney J, Schneider-Lindner V, Brassard P, Suissa S. Mortality after infection with methicillin-resistant Staphylococcus aureus (MRSA) diagnosed in the community. BMC Medicine 2008, 6:2. 10.1186/1741-7015-6-2, 2259374, 18234115.
2. Klevens R, Morrison M, Nadle J, Petit S, Gershman K, Ray S, Harrison L, Lynfield R, Dumyati G, Townes J, Craig A, Zell E, Fosheim G, McDougal L, Carey R, Fridkin S. Invasive methicillin-resistant Staphylococcus aureus infections in the United States. JAMA 2007, 298:1763-1771. 10.1001/jama.298.15.1763, 17940231.
3. Grundmann H, Aires-de-Sousa M, Boyce J, Tiemersma E. Emergence and resurgence of methicillin-resistant Staphylococcus aureus as a public-health threat. Lancet 2006, 368:874-885. 10.1016/S0140-6736(06)68853-3, 16950365.
4. Lowry F. Antimicrobial resistance: the example of Staphylococcus aureus. J Clin Invest 2003, 111:1265-1273. 154455, 12727914.
5. David M, Daum R. Community-Associated Methicillin-Resistant Staphylococcus aureus: Epidemiology and Clinical Consequences of an Emerging Epidemic. Clinical Microbiol Rev 2010, 23:616-687.
6. Mangili A, Bica I, Snydman D, Hamer D. Daptomycin-resistant, methicillin-resistant Staphylococcus aureus bacteremia. Clin Infect Dis 2005, 40:1058-1060. 10.1086/428616, 15825002.
7. Weigel L, Donlan R, Shin D, Jensen B, Clark N, McDougal L, Zhu W, Musser K, Thompson J, Kohlerschmidt D, Dumas N, Limberger R, Patel J. High-level vancomycin-resistant Staphylococcus aureus (VRSA). Antimicrob Agents Chemother 2007, 51:231-238. 10.1128/AAC.00576-06, 1797660, 17074796.
8. Sakoulas G, Moellering R. Increasing antibiotic resistance among methicillin-resistant Staphylococcus aureus strains. Clin Infect Dis 2008, 1:S360-367.
9. Fridkin S, Hageman J, Morrison M, Sanza L, Como-Sabetti K, Jernigan J, Harriman K, Harrison L, Lynfield R, Farley M. Methicillin-resistant Staphylococcus aureus disease in three communities. N Engl J Med 2005, 352:1436-1444. 10.1056/NEJMoa043252, 15814879.
10. Diekema D, Pfaller M, Schmitz F, Smayevsky J, Bell J, Jones R, Beach M. Survey of infections due to Staphylococcus species: frequency of occurrence and antimicrobial susceptibility of isolates collected in the United States, Canada, Latin America, Europe, and the Western Pacific region for the SENTRY Antimicrobial Surveillance Program, 1997-1999. Clin Infect Dis 2001, 32:S114-S132. 10.1086/320184, 11320452.
11. Hancock REW. Peptide antibiotics. Lancet 1997, 349:418-422. 10.1016/S0140-6736(97)80051-7, 9033483.
12. Brogden KA. Antimicrobial peptides: pore formers or metabolic inhibitors in bacteria?. Nature Rev Microbiol 2005, 3:238-250.
13. Clark DP, Durell S, Maloy WL, Zasloff M. Ranalexin A novel antimicrobial peptide from bullfrog (Rana catesbeiana) skin, structurally related to the bacterial antibiotic, polymyxin. J Biol Chem 1994, 269:10849-10865.
14. Giacommetti A, Cirioni O, Greganti G, Quarta M, Scalise G. In vitro activities of membrane-active peptides against Gram-positive and Gram-negative aerobic bacteria. Antimicrob Agents Chemother 1998, 12:3320-3324. 106047, 9835539.
15. McDermott P. Antimicrobials: Modes of Action and Mechanisms of Resistance. Intl J Toxicol 2003, 22:135-143.
16. Franklin T, Snow G. Biochemistry and molecular biology of antimicrobial drug action. 2005, Springer.
17. Hutter B, Schaab C, Albrecht S, Borgmann M, Brunner NA, Freiberg C, Ziegelbauer K, Rock CO, Ivanov I, Loferer H. Prediction of mechanisms of action of antibacterial compounds by gene expression profiling. Antimic Agents Chemother 2004, 48:2838-2844.
18. Freiberg C, Fischer HP, Brunner NA. Discovering the mechanism of action of novel antibacterial agents through transcriptional profiling of conditional mutants. Antimic Agents Chemother 2005, 49:749-759.
19. Le Roch K, Johnson J, Ahiboh H, Chung D, Prudhomme J, Plouffe D, Henson K, Zhou Y, Witola W, Yates J, Mamoun C, Winzeler E, Vial H. A systematic approach to understand the mechanism of action of the bisthiazolium compound T4 on the human malaria parasite, Plasmodium falciparum. BMC Genomics 2008, 9:513. 10.1186/1471-2164-9-513, 2596145, 18973684.
20. Iorio F, Bosotti R, Scacheri E, Belcastro V, Mithbaokar P, Ferriero R, Murino L, Tagliaferri R, Brunetti-Pierri N, Isacchi A, Bernardo D. Discovery of drug mode of action and drug repositioning from transcriptional responses. PNAS 2010, 107:14621-14626. 10.1073/pnas.1000138107, 2930479, 20679242.
21. Gardner T, Bernardo D, Lorenz D, Collins J. Inferring Genetic Networks and Identifying Compound Mode of Action via Expression Profiling. Science 2003, 301:102-105. 10.1126/science.1081900, 12843395.
22. Berger S, Iyengar R. Network Analyses in Systems Pharmacology. Bioinformatics 2009, 25:2466-2472. 10.1093/bioinformatics/btp465, 2752618, 19648136.
23. Lee I, Date S, Adai A, Marcotte E. A Probabilistic Functional Network of Yeast Genes. Science 2004, 26:1555-1558.
24. Fraser G, Marcotte E. A probabilistic view of gene function. Nat Genet 2004, 36:559-564. 10.1038/ng1370, 15167932.
25. Zhong W, Sternberg P. Genome-Wide Prediction of C elegans Genetic Interactions. Science 2006, 311:1481-1484. 10.1126/science.1123287, 16527984.
26. Murchan S, Aucken H, O'Neil G, Ganner M, Cookson B. Emergence, Spread and Characterization of Phage Variants of Epidemic Methicillin-Resistant Staphylococcus aureus 16 in England and Wales. J Clin Microbiol 2004, 42:5154-5160. 10.1128/JCM.42.11.5154-5160.2004, 525207, 15528709.
27. Ashburner M, Ball CA, Blake JA, Botstein D, Butler H, Cherry JM, Davis AP, Dolinski K, Dwight SS, Eppig JT, Harris MA, Hill DP, Issel-Tarver L, Kasarskis A, Lewis S, Matese JC, Richardson JE, Ringwald M, Rubin G, Sherlock G. Gene Ontology: tool for the unification of biology. Nat Genet 2000, 25:25-29. 10.1038/75556, 3037419, 10802651.
28. Waters KM, Pounds JG, Thrall BD. Data merging for integrated microarray and proteomic analysis. Brief Funct Genomic Proteomic 2006, 5:261-272. 10.1093/bfgp/ell019, 16772273.
29. Conrads K, Yi M, Simpson K, Lucas D, Camalier C, Yu L, Veenstra T, Stephens R, Conrads T, Beck G. A Combined Proteome and Microarray Investigation of Inorganic Phosphate-induced Pre-osteoblast Cells. Mol Cell Proteomics 2005, 4:1284-1296. 10.1074/mcp.M500082-MCP200, 15958391.
30. Apweiler R, Bairoch A, Wu CH, Barker WC, Boeckmann B, Ferro S, Gasteiger E, Huang H, Lopez R, Magrane M, Martin MJ, Natale DA, O'Donovan C, Redaschi N, Yeh LL. UniProt: the Universal Protein knowledgebase. Nucl Acids Res 2004, 32:D115-D119. 10.1093/nar/gkh131, 308865, 14681372.
31. Jensen LJ, Kuhn M, Stark M, Chaffron S, Creevey C, Muller J, Doerks T, Julien P, Roth A, Simonovic M, Bork P, von Mering C. STRING 8 - a global view on proteins and their functional interactions in 630 organisms. Nucl Acids Res 2009, 37:D412-416. 10.1093/nar/gkn760, 2686466, 18940858.
32. Kawashima S, Katayama T, Araki M, Hirakawa M. From genomics to chemical genomics: new developments in KEGG. Nucleic Acids Res 2006, 34:D354-357. 10.1093/nar/gkj102, 1347464, 16381885.
33. Ravasz E, Somera AL, Mongru DA, Oltvai ZN, Barabasi AL. Hierarchical Organization of Modularity in Metabolic Networks. Science 2002, 297:1551-1555. 10.1126/science.1073374, 12202830.
34. Yamada T, Bork P. Evolution of biomolecular networks -- lessons from metabolic and protein interactions. Nat Rev Mol Cell Biol 2009, 10:791-803. 10.1038/nrm2787, 19851337.
35. vanDongen S. Graph clustering by flow simulation. PhD thesis 2000, University of Utrecht, The Netherlands.
36. Taylor IW, Linding R, Warde-Farley D, Liu Y, Pesquita C, Faria D, Bull S, Pawson T, Morris Q, Wrana J. Dynamic modularity in protein interaction networks predicts breast cancer outcome. Nat Biotech 2009, 27:199-204.
37. Burts M, Williams W, DeBord K, Missiakas D. EsxA and EsxB are secreted by an ESAT-6-like system that is required for the pathogenesis of Staphylococcus aureus infections. PNAS 2005, 102:1169-1174. 10.1073/pnas.0405620102, 545836, 15657139.
38. Krogh A, Larsson B, vonHeijne G, Sonnhammer E. Predicting transmembrane protein topology with a hidden Markov model: Application to complete genomes. Journal of Molecular Biology 2001, 305:567-580. 10.1006/jmbi.2000.4315, 11152613.
39. Servant F, Bru C, Carrïre S, Courcelle E, Gouzy J, Peyruc D, Kahn D. ProDom: Automated clustering of homologous domains. Brief Bioinf 2002, 3:246-251.
40. Finn RD, Tate J, Mistry J, Coggill P, Sammut J, Hotz H, Ceric G, Forslund K, Eddy S, Sonnhammer E, Bateman A. The Pfam protein families database. Nucleic Acids Res 2008, 36:D281-D288. 10.1093/nar/gkn226, 2238907, 18039703.
41. Price M, Huang K, Alm E, Arkin P. A Novel Method for Accurate Operon Predictions in All Sequenced Prokaryotes. Nucleic Acids Res 2005, 33:880-892. 10.1093/nar/gki232, 549399, 15701760.
42. Pertea M, Ayanbule K, Smedinghoff M, Salzberg S. OperonDB: a comprehensive database of predicted operons in microbial genomes. Nucleic Acids Res 2009, 37:D479-D482. 10.1093/nar/gkn784, 2686487, 18948284.
43. Papp-Wallace K, Maguire M. Manganese Transport and the Role of Manganese in Virulence. Ann Rev Microbiol 2006, 60:187-209.
44. Cornelissen CN, Sparling PF. Iron piracy: acquisition of transferrin-bound iron by bacterial pathogens. Mol Microbiol 1994, 14:843-850. 10.1111/j.1365-2958.1994.tb01320.x, 7715446.
45. Morrissey JA, Cockayne A, Hill PJ, Williams P. Molecular cloning and analysis of a putative siderophore ABC transporter from Staphylococcus aureus. Infect Immun 2000, 68:6281-6288. 10.1128/IAI.68.11.6281-6288.2000, 97710, 11035736.
46. Hair P, Ward M, Semmes O, Foster T, Cunnion K. Staphylococcus aureus clumping factor A binds to complement regulator factor I and increases factor I cleavage of C3b. J Infect Dis 2008, 198:125-133. 10.1086/588825, 18544012.
47. Fujimoto D, Bayles K. Opposing Roles of the Staphylococcus aureus Virulence Regulators, Agr and Sar, in Triton X-100- and Penicillin-Induced Autolysis. J Bacteriol 1998, 180:3724-3726. 107347, 9658022.
48. Dubrac S, Boneca I, Poupel O, Msadek T. New Insights into the WalK/WalR (YycG/YycF) Essential Signal Transduction Pathway Reveal a Major Role in Controlling Cell Wall Metabolism and Biofilm Formation in Staphylococcus aureus. J Bacteriol 2007, 189:8257-8269. 10.1128/JB.00645-07, 2168699, 17827301.
49. Downer R, Roche F, Park P, Mecham R, Foster T. The Elastin-binding Protein of Staphylococcus aureus (EbpS) Is Expressed at the Cell Surface as an Integral Membrane Protein and Not as a Cell Wall-associated Protein. J Biol Chem 2002, 277:243-250.
50. Rossi J, Bischoff M, Wada A, Berger-Bachi B. MsrR, a putative cell envelope-associated element involved in Staphylococcus aureus sarA attenuation. Antimic Agents Chemother 2003, 47:2558-2564.
51. Kaito C, Morishita D, Matsumoto Y, Kurokawa K, Sekimizu K. Novel DNA binding protein SarZ contributes to virulence in Staphylococcus aureus. Mol Microbiol 2006, 62:1601-1617. 10.1111/j.1365-2958.2006.05480.x, 17087772.
52. Cheung AL, Koomey JM, Butler CA, Projan SJ, Fischetti VA. Regulation of exoprotein expression in Staphylococcus aureus by a locus (sar) distinct from agr. PNAS 1992, 89:6462-6466. 10.1073/pnas.89.14.6462, 49521, 1321441.
53. Gemmell CG. Antibiotics and the expression of staphylococcal virulence. J Antimic Chemother 1995, 36:283-291.
54. Yin S, Daum RS, Boyle-Vavra S. VraSR two-component regulatory system and its role in induction of pbp2 and vraSR expression by cell wall antimicrobials in Staphylococcus aureus. Antimic Agents Chemother 2006, 50:336-343.
55. Kuroda M, Kuroda H, Oshima T, Takeuchi F, Mori H, Hiramatsu K. Two-component system VraSR positively modulates the regulation of cell-wall biosynthesis pathway in Staphylococcus aureus. Mol Microbiol 2003, 49:807-821.
56. Utaida S, Dunman PM, Macapagel D, Murphy E, Projan SJ, Singh VK, Jayaswal RK, Wilkinson BJ. Genome-wide transcriptional profiling of the response of Staphylococcus aureus to cell-wall active antibiotics reveals a cell-wall-stress stimulon. Microbiol 2003, 149:2719-2732.
57. Boyle-Vavra S, Yin S, Challapalli M, Daum RS. Transcriptional induction of the penicillin-binding protein 2 gene in Staphylococcus aureus by cell-wall active antibiotics oxacillin and vancomycin. Antimic Agents Chemother 2003, 47:1028-1036.
58. Maki H, McCallum N, Bischoff M, Wada A, Berger-Bachi B. tcaA inactivation increases glycopeptide resistance in Staphylococcus aureus. Antimic Agents Chemother 2004, 48:1953-1959.
59. McAleese F, Wu SW, Sieradzki K, Dunman P, Murphy E, Projan S, Tomasz A. Overexpression of genes of the cell wall stimulon in clinical isolates of Staphylococcus aureus exhibiting vancomycin-intermediate-S aureus-type resistance to vancomycin. J Bacteriol 2006, 188:1120-1133. 10.1128/JB.188.3.1120-1133.2006, 1347359, 16428416.
60. Lysenko E, Ogura T, Cutting S. Characterisation of the ftsH gene of Bacillus subtilis. Microbiology 1997, 143:971-978. 10.1099/00221287-143-3-971, 9084181.
61. Lithgow JK, Ingham EI, Foster S. Role of the hprT-ftsH locus in Staphylococcus aureus. Microbiology 2004, 150:373-381. 10.1099/mic.0.26674-0, 14766915.
62. Forsyth RA, Haselbeck RJ, Ohlsen KL, Yamamoto H, Trawick J, Wall D, Wang L, Brown-Driver V, Froelich J, Kedar GC, King P, McCarthy M, Malone C, Misiner B, Robbins D, Tan Z, Zhu Z, Carr G, Mosca D, Zamudio C, Foulkes JG, Zyskind J. A genome-wide strategy for the identification of essential genes in Staphylococcus aureus. Mol Microbiol 2002, 43:1387-1400. 10.1046/j.1365-2958.2002.02832.x, 11952893.
63. Singh VK, Jayaswal RK, Wilkinson BJ. Cell wall-active antibiotic induced proteins of Staphylococcus aureus identified using a proteomic approach. FEMS Microbiol Lett 2001, 199:79-84.
64. Renzoni A, Barras C, Francois P, Charbonnier Y, Huggler E, Garzoni C, Kelley WL, Majcherczyk P, Schrenzel J, Lew DP, Vaudaux P. Transcriptomic and functional analysis of an autolysis-deficient, teicoplanin-resistant derivative of methicillin-resistant Staphylococcus aureus. Antimic Agents Chemother 2006, 50:3048-3061.
65. Midorikawa K, Ouhara K, Komatsuzawa H, Kawai T, Yamada S, Fujiwara T, Yamazaki K, Sayama K, Taubman MA, Kurihara H, Hashimoto K, Sugai M. Staphylococcus aureus susceptibility to innate antimicrobial peptides, β-defensins and CAP18, expressed by human keratinocytes. Inf Immun 2003, 71:3730-3739.
66. Viola R. The Central Enzymes of the Aspartate Family of Amino Acid Biosynthesis. Acc Chem Res 2001, 34:339-349. 10.1021/ar000057q, 11352712.
67. Belcheva A, Golemi-Kotra D. A Close-up View of the VraSR Two-component System A mediator of Staphylococcus aureus Response to Cell Wall Damage. J Biol Chem 2008, 283:12354-12364. 10.1074/jbc.M710010200, 18326495.
68. McCallum N, Brassinga AKC, Sifri CD, Berger-Bachi B. Functional characterisation of TcaA: minimal requirement for teicoplanin susceptibility and role in Caenorhabditis elegans virulence. Antimic Agents Chemother 2007, 51:3836-3843.
69. Mitchell P, Moyle J. Autolytic Release and Osmotic Properties of ' Protoplasts ' from Staphylococcus aureus. J Gen Microbiol 1957, 16:184-194.
70. Giesbrecht P, Kersten T, Maidhof H, Wecke J. Staphylococcal Cell Wall: Morphogenesis and Fatal Variations in the Presence of Penicillin. Microbiol Mol Biol Rev 1998, 62:1371-1414. 98950, 9841676.
71. Li Y, Zang Y. PhoU is a persistence switch involved in persister formation and tolerance to multiple antibiotics and stresses in Escherichia coli. Antimicrob Agents Chemother 2007, 51:2092-2099. 10.1128/AAC.00052-07, 1891003, 17420206.
72. Rogers PD, Liu TT, Barker KS, Hilliard GM, English BK, Thornton J, Swiatlo E, McDaniel LS. Gene expression profiling of the response of Streptococcus pneumoniae to penicillin. J Antimic Chemother 2007, 59:616-626.
73. Banerjee SK, Bhatt K, Misra P, Chakraborti PK. Involvement of a natural transport system in the process of efflux-mediated drug resistance in Mycobacterium smegmatis. Mol Gen Genet 2000, 262:949-956. 10.1007/PL00008663, 10660056.
74. Gefen O, Balaban NQ. The importance of being persistent: heterogeneity of bacterial populations under antibiotic stress. FEMS Microbiol Rev 2009, 33:707-717.
75. McCallum N, Karauzum H, Getzmann R, Bischoff M, Majcherczyk P, Berger-Bachi B, Landmann R. In vivo survival of teicoplanin-resistant Staphylococcus aureus and fitness cost of teicoplanin resistance. Antimic Agents Chemother 2006, 50:2352-2360.
76. Hiramatsu T, Kodama K, Kuroda T, Mizushima T, Tsuchiya T. A putative multisubunit Na+/H+ antiporter from Staphylococcus aureus. J Bacteriol 1998, 180:6642-6648. 107768, 9852009.
77. Swartz T, Ito M, Ohira T, Natsui S, Hicks D, Krulwich T. Catalytic Properties of Staphylococcus aureus and Bacillus Members of the Secondary Cation/Proton Antiporter-3 (Mrp) Family Are Revealed by an Optimized Assay in an Escherichia coli Host. J Bacteriol 2007, 189:3081-3090. 10.1128/JB.00021-07, 1855852, 17293423.
78. Pané-Farré J, Jonas B, Förstner K, Engelmann S, Hecker M. The σB regulon in Staphylococcus aureus and its regulation. Int J Med Microbiol 2009, 296:237-258.
79. Nucifora G, Chu L, Misra TK, Silver S. Cadmium resistance from Staphylococcus aureus plasmid pI258 cadA gene results from a cadmium-efflux ATPase. PNAS 1989, 86:3544-3548. 10.1073/pnas.86.10.3544, 287174, 2524829.
80. Jin J, Guffanti AA, Bechhofer DH, Krulwich TA. Tet(L) and Tet(K) tetracycline-divalent metal/H+ antiporters: characterisation of multiple catalytic modes and a mutagenesis approach to differences in their efflux substrate and coupling ion preferences. J Bacteriol 2002, 184:4722-4732. 10.1128/JB.184.17.4722-4732.2002, 135290, 12169596.
81. Xiong A, Jayaswal RK. Molecular characterisation of a chromosomal determinant conferring resistance to zinc and cobalt ions in Staphylococcus aureus. J Bacteriol 1998, 180:4024-4029. 107394, 9696746.
82. Fraser K, Wiedmann M, Boor K, O'Byrne C. Role of sigmaB in regulating the compatible solute uptake systems of Listeria monocytogenes: osmotic induction of opuC is sigmaB dependent. Appl Environ Microbiol 2006, 69:2015-2022. PMC154801, 12676677.
83. Peschel A, Otto M, Jack RW, Kalbacher H, Jung G, Gotz F. Inactivation of the dlt operon in Staphylococcus aureus confers sensitivity to defensins, protegrins, and other antimicrobial peptides. J Biol Chem 1999, 274:8405-8410. 10.1074/jbc.274.13.8405, 10085071.
84. Blombach B, Schreiner M, Holatko J, Bartek T, Oldiges M, Eikmanns B. L-valine production with pyruvate dehydrogenase complex-deficient Cornyebacterium glutamicum. Appl Env Microbiol 2007, 73:2079-2084.
85. Peschel A, Sahl HG. The co-evolution of host cationic antimicrobial peptides and microbial resistance. Nat Rev Microbiol 2006, 4:529-536. 10.1038/nrmicro1441, 16778838.
86. Friedrich C, Moyles D, Beveridge T, Hancock R. Antibacterial action of structurally diverse cationic peptides on Gram-positive bacteria. Antimic Agents Chemother 2000, 44:2086-2092.
87. Drago R, Vecchi E, Nicola L, Gismondo M. In vitro evaluation of antibiotics' combinations for empirical therapy of suspected methicillin resistant Staphylococcus aureus severe respiratory infections. BMC Infect Disease 2007, 7(111). 2025599, 17888153.
88. Kasiakou S, Michalopoulos A, Soteriades E, Samonis G, Sermaides G, Falagas M. Combination Therapy with Intravenous Colistin for Management of Infections Due to Multidrug-Resistant Gram-Negative Bacteria in Patients without Cystic Fibrosis. Antimic Agents Chemother 2005, 49:3136-3146.
89. Li M, Cha DJ, Lai Y, Villaruz AE, Sturdevant DE, Otto M. The antimicrobial peptide-sensing system aps of Staphylococcus aureus. Mol Microbiol 2007, 66:1136-1147. 10.1111/j.1365-2958.2007.05986.x, 17961141.
90. Li M, Lai Y, Villaruz AE, Cha DJ, Sturdevant DE, Otto M. Gram-positive three-component antimicrobial peptide-sensing system. PNAS 2007, 104:9469-9474. 10.1073/pnas.0702159104, 1890518, 17517597.
91. Benjamini Y, Yekutieli Y. The control of the false discovery rate in multiple testing under dependency. Ann Statist 2001, 29:1165-1188.
92. Vizcaino J, Cote R, Reisinger F, Foster J, Mueller M, Rameseder J, Hermjakob H, Martens L. A guide to the Proteomics Identifications Database proteomics data repository. Proteomics 2009, 9:4276-4283. 10.1002/pmic.200900402, 2970915, 19662629.
93. Witney AA, Marsden GL, Holden MTG, Stabler RA, Husain SE, Vass JK, Butcher PD, Hinds J, Lindsay JA. Design, validation and application of a seven strain Staphylococcus aureus microarray for comparative genomics. Appl Environ Microbiol 2005, 71:7504-7514. 10.1128/AEM.71.11.7504-7514.2005, 1287626, 16269792.
94. Benjamini Y, Hochberg Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J Royal Stat Soc Series B (Methodological) 1995, 57:289-300., http://www.jstor.org/stable/2346101
95. R Development Core Team R: a language and environment for statistical computing 2010, R foundation for statistical computing, Vienna, Austria, R Development Core Team.
96. vanRijsbergen C. Information Retrieval 1979, Butterworths, UK, Second.
97. Altschul S, Madden T, Schaffer A, Zhang Z, Miller W, Lipman D. Gapped BLAST and PSI-BLAST: a new generation of protein database search programs. Nucleic Acids Res 1997, 1:3389-3402. PMC146917, 9254694.
98. Assenov Y, Ramirez F, Schelhorn S, Lengauer T, Albrecht A. Computing topological parameters of biological networks. Bioinformatics 2008, 24:282-284. 10.1093/bioinformatics/btm554, 18006545.
99. Barker WC, Garavelli JS, Huang H, McGarvey PB, Orcutt BC, Srinivasarao GY, Xiao C, Yeh L-SL, Ledley RS, Janda JF, Pfeiffer F, Mewes H, Tsugita A, Wu C. The Protein Information Resource (PIR). Nucl Acids Res 2000, 28:41-44. 10.1093/nar/28.1.41, 102418, 10592177.
100. Pfaffl MW. A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res 2000, 29:2002-2007. PMC55695, 11328886.
101. McCallum N, Spehar G, Bischoff M, Berger-Bachi B. Strain dependence of the cell wall-damage induced stimulon in Staphylococcus aureus. Biochim Biophys Acta 2006, 1760:1475-1481.
102. Maslov S, Sneppen K. Specificity and stability in topology of protein networks. Science 2002, 296:910-913. 10.1126/science.1065103, 11988575.
103. Rubinov M, Sporns O. Complex network measures of brain connectivity: Uses and interpretations. Neuroimage 2009, 52:1059-1069.
104. Shannon P, Markiel A, Ozier O, Baliga N, Wang J, Ramage D, Amin N, Schwikowski B, Ideker T. Cytoscape, a software environment for integrated models of biomolecular interaction networks. Genome Res 2003, 13:2498-2504. 10.1101/gr.1239303, 403769, 14597658.